Eikon Therapeutics, Inc. (EIKN) Institutional Ownership and Insiders Activity

Eikon Therapeutics, Inc. (EIKN) is widely held by institutional investors, with 75 firms reporting positions valued at approximately $339.44M based on SEC Form 13F filings for the quarter ended June 30, 2026.

Fmr Llc is the largest disclosed holder, reporting approximately $65.17M in EIKN holdings in its latest filing.